Application 216185

Type
NDA
Sponsor
AUCTA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001MOTPOLY XRLACOSAMIDECAPSULE, EXTENDED RELEASE;ORAL100MGYesNo
002MOTPOLY XRLACOSAMIDECAPSULE, EXTENDED RELEASE;ORAL150MGYesNo
003MOTPOLY XRLACOSAMIDECAPSULE, EXTENDED RELEASE;ORAL200MGYesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
78754SUPPL 2024-06-10
78747SUPPL 2024-06-10
78746SUPPL 2024-06-10
74975ORIG 2023-08-03
74183ORIG 2023-05-05
74181ORIG 2023-05-05